Detalhe da pesquisa
1.
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
J Headache Pain
; 23(1): 38, 2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305579
2.
Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index.
Front Neurol
; 13: 846717, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295829
3.
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men.
Front Neurol
; 12: 774341, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975732